Top Markets
Coin of the day
Paragon 28, Inc. Paragon 28, Inc.

Paragon 28, Inc.

FNA
Clasificación en acciones #9071
Paragon 28, Inc. is a medical device company specializing in the development,... Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.
Precio por acción
$13.09
Última sincronización: 2025-04-17
Capitalización bursátil
$1.10B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Paragon 28, Inc. (FNA)

Categoría

Ingresos de Paragon 28, Inc. (FNA)
Ingresos en Dec 2024 TTM: $256.18M
Según los últimos informes financieros de Paragon 28, Inc., los ingresos actuales de la empresa (TTM) son $256.18M. En 2023, la empresa obtuvo unos ingresos de $216.39M un aumento con respecto a los ingresos del año 2022, que fueron de $181.38M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Paragon 28, Inc. desde 2019 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $256.18M 0.00%
2024 $256.18M 18.39%
2023 $216.39M 19.30%
2022 $181.38M 23.00%
2021 $147.46M 32.87%
2020 $110.98M 4.42%
2019 $106.28M 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$46.59B 18,084.34%
US
$25.84B 9,985.41%
US
$35.48B 13,751.09%
IE
$21.00B 8,095.74%
US
- -
DE